Healthcare News Health Insurance Nightmare: Health Care Coverage Cost Predicted To Soar Next Year 6 years ago
New Drugs FDA Approves Rituxan (rituximab) for Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) in Children 6 years ago
New Drugs FDA Approves Mavyret (glecaprevir/pibrentasvir) Treatment Duration of Eight Weeks for Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis Across All Genotypes 6 years ago
Pharma Industry News Significant gaps remain in UK’s no-deal Brexit prep, says NAO report 6 years ago
Pharma Industry News GSK and Apotex join generic Zantac recalls as carcinogen concerns mount 6 years ago